Skip to content

Apotheek Baert S.: what changed

What changed

Apotheek Baert S.

BE 0860.904.197
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€1,185
2024 · -€11,899+€13,083
Equity
-€41,829
2024 · -€43,013+€1,185
Cash
€135
2024 · €8,006-€7,871
Balance sheet total
€194,387
2024 · €196,984-€2,597

Largest movements

2024 to 2025
Assets
  • Cash -€7,871

    down €7,871 (-98.3%), from €8,006 to €135

    mainly Receivables within one year (-€5,677) and Other debts (-€2,878)

  • Receivables within one year +€5,677

    up €5,677 (+3.0%), from €188,096 to €193,773

    of which Other amounts receivable: +€5,788

Equity and liabilities
  • Other debts -€2,878

    down €2,878 (-2.0%), from €144,912 to €142,034

Income statement
  • Gross operating margin +€12,295

    up €12,295 (+61.0%), from -€20,168 to -€7,873

  • Financial income +€761

    up €761 (+8.2%), from €9,275 to €10,037

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€11,899
Gross operating margin +€12,295
Other operating charges -€41
Financial income +€761
Financial charges +€68
Result 2025 €1,185
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€7,871
Investment €0
Financing €0
Cash 2024 €8,006
Net result for the year +€1,185
Receivables within one year -€5,677
Deferred charges and accrued income +€403
Trade debts -€787
Tax, wage and social debts -€117
Other debts -€2,878
Cash 2025 €135
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €196,984 €194,387 -€2,597 -1.3%
Fixed assets 21/28 €479 €479 = 0.0%
Financial fixed assets 28 €479 €479 = 0.0%
Current assets 29/58 €196,505 €193,908 -€2,597 -1.3%
Amounts receivable within one year 40/41 €188,096 €193,773 +€5,677 +3.0%
Trade receivables 40 €1,962 €1,851 -€111 -5.7%
Other amounts receivable 41 €186,134 €191,922 +€5,788 +3.1%
Cash at bank and in hand 54/58 €8,006 €135 -€7,871 -98.3%
Deferred charges and accrued income 490/1 €403 - -€403
Total equity and liabilities 10/49 €196,984 €194,387 -€2,597 -1.3%
Equity 10/15 -€43,013 -€41,829 +€1,185 +2.8%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €2,000 €2,000 = 0.0%
Non-distributable reserves 130/1 €2,000 €2,000 = 0.0%
Reserves not available under the articles 1311 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 -€65,013 -€63,829 +€1,185 +1.8%
Amounts payable 17/49 €239,997 €236,215 -€3,782 -1.6%
Amounts payable within one year 42/48 €239,997 €236,215 -€3,782 -1.6%
Current portion of amounts payable after more than one year 42 €94,000 €94,000 = 0.0%
Trade debts 44 €968 €182 -€787 -81.3%
Suppliers 440/4 €968 €182 -€787 -81.3%
Taxes, remuneration and social security 45 €117 - -€117
Taxes 450/3 €117 - -€117
Other amounts payable 47/48 €144,912 €142,034 -€2,878 -2.0%
Other operating charges 640/8 €115 €156 +€41 +35.7%
Gross operating margin 9900 -€20,168 -€7,873 +€12,295 +61.0%
Operating profit (loss) 9901 -€20,283 -€8,029 +€12,254 +60.4%
Financial income 75/76B €9,275 €10,037 +€761 +8.2%
Recurring financial income 75 €9,275 €10,037 +€761 +8.2%
Financial charges 65/66B €891 €823 -€68 -7.6%
Recurring financial charges 65 €891 €823 -€68 -7.6%
Profit (loss) for the period before taxes 9903 -€11,899 €1,185 +€13,083
Profit (loss) for the period 9904 -€11,899 €1,185 +€13,083
Profit (loss) for the period to be appropriated 9905 -€11,899 €1,185 +€13,083
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.